Article Versions Notes

Rodríguez-Castejón J, Alarcia-Lacalle A, Gómez-Aguado I, Vicente-Pascual M, Solinís Aspiazu MÁ, del Pozo-Rodríguez A, Rodríguez-Gascón A. α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease Mice. Pharmaceutics. 2021; 13(6):771. https://doi.org/10.3390/pharmaceutics13060771

Rodríguez-Castejón, Julen, Ana Alarcia-Lacalle, Itziar Gómez-Aguado, Mónica Vicente-Pascual, María Ángeles Solinís Aspiazu, Ana del Pozo-Rodríguez, and Alicia Rodríguez-Gascón. 2021. "α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease Mice" Pharmaceutics 13, no. 6: 771. https://doi.org/10.3390/pharmaceutics13060771

Rodríguez-Castejón, J., Alarcia-Lacalle, A., Gómez-Aguado, I., Vicente-Pascual, M., Solinís Aspiazu, M. Á., del Pozo-Rodríguez, A., & Rodríguez-Gascón, A. (2021). α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease Mice. Pharmaceutics, 13(6), 771. https://doi.org/10.3390/pharmaceutics13060771